Stem Cell Therapy for Scleroderma"
Richard K. Burt, MD
Patient Education Forum,
New York, NY
April 24, 2016
About Dr. Burt:
MD: Saint Louis University
Residency: Baylor Affiliated Hospitals
Fellowship: National Institutes of Health
Board Certification: Hematology/Oncology, Internal
The Division of Immunotherapy and Autoimmune Diseases
(DIAD) at Northwestern is the only center in the world
devoted to a unique area of treatment and research, utilizing
stem cell transplantation in clinical trials for autoimmune
and vascular diseases. DIAD pioneered and performed
America’s first hematopoietic stem cell transplants to
treat: Multiple Sclerosis (MS), Diabetes, Lupus, Crohn’s,
Rheumatoid Arthritis, Chronic Inflammatory Demyelinating
Polyneuropathy (CIDP), Pemphigus, Dermatomyositis, Devic’s
Disease, Myasthenia Gravis, Polymositis and Scleroderma.
Dr. Burt has held 14 grants within his area of research during
his career at Northwestern. He has published more than
150 articles in well known, peer reviewed journals on topics
such as oncology, immunology, cardiology, scleroderma, MS, lupus and more.
The information presented on this site is intended for educational purposes only. Neither the featured speakers, nor the Scleroderma Foundation, nor Starlight Productions (the producers of these videos) suggest, recommend or endorse any specific treatment for any individual. Patients are advised consult their own health care providers for treatment options.